Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.

Slides:



Advertisements
Similar presentations
Cervical Screening Guidelines - for now and the future - Meg McLachlin, MD, FRCPC.
Advertisements

Cervical Issues Annual update 2010 Tamsin Groom. Overview of screening and management Do’s and Don’ts The “suspicious cervix” Quiz.
Clinical Use of HPV DNA Testing Thomas C. Wright, Jr. College of Physicians and Surgeons of Columbia University.
Cervical Screening and HPV testing
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Updates on Pap Smear Guidelines 2014
Speaker: Decca Mohammed, MD.  Statistics for cervical cancer and HPV  Association of HPV to cervical cancer, and other cancers  Prevention  Screening.
MS&E 220 Project Yuan Xiang Chew, Elizabeth A Hastings, Morris Jinhui Zhang Probabilistic Analysis of Cervical Cancer Screening and Vaccination.
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer: Molecular Impact of an Infectious Disease.
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
HPV and cervical screening Test of cure
Screening for Cervical Cancer
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA Roger J Rand.
Benign and premalignant disease of the cervix
Cervical Cancer and HIV: Interactions and Interventions Jean R. Anderson, M.D. Jhpiego, an affiliate of Johns Hopkins University The Johns Hopkins University.
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Human Papilloma virus testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Human Papillomavirus? Human papilloma.
PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.
COLPOSCOPY Cervical Screening QARC Training School October 2012.
AN AUDIT OF PAP SMEAR, COLPOSCOPY AND HISTOLOGY RESULTS FROM IN TUNGARU CENTRAL HOSPITAL (KIRIBATI)
Cytopathology: Technique and Interpretation
HPV and Cervical Cancer Screening and Prevention.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Screening Tests for Brest & Cervical Cancer
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
Cervical Cancer Prevention
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Cancer of Cervix Shashi. Sep-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. Potentially curable if detected early.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
HPV VACCINATION Dr Frida Mghamba 2 nd East Africa WE CAN Summit 11 th September 2014.
Nursing Process HPV.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
TEMPLATE DESIGN © Outcome of Large Loop Excision of Transformation Zone (LLETZ ) in women over forty at two London Hospitals.
HspE7 INFECTIOUS DISEASE VACCINE FOR THE TREATMENT OF CERVICAL CARCINOMA.
Dr. Phimpha Paboriboune, Scientific Director,
Sheffield Gynaecological Cancer CentreSheffield Teaching Hospitals PRIMARY HPV SCREENING A view from colposcopy John Tidy Consultant Gynaecological Oncologist.
Cytologic Findings in Type 2 Cervical Carcinomas: Some Cervical Carcinomas are more Difficult to Prevent with Screening R. Marshall Austin MD,PhD Magee-Womens.
Premalignant lesions of the cervix. Applied anatomy.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
HPV and Pap Guidelines Jennifer Johnson MD. Objectives 1. Define the new PAP guidelines. 2. Identify the historical trends and new evidence resulting.
WACCPP rolling PowerPoint. INSTRUCTIONS  This PowerPoint presentation has been designed for use as a rolling backdrop at presentations or events  Before.
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
Cytopathology Feb
Chapter 29 Human Papilloma Virus Infection and Immunity.
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Cancer prevention and early detection
CERVIX.
INTRODUCTION: CERVICAL CANCER SCREENING
Treatment Options for Cervical Cancer in Low Income Countries
Cervical Cancer Colposcopy & Treatment
Cervical Screening for Dysplasia and Cancer in Patients with HIV
Screening to Prevent Invasive Cervical Cancer (Resource-Stratified)
SH-sheikhhasani Gyn-oncologist
The National Cervical Screening Programme
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA
Presentation transcript:

Screening for cervical cancer

Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED

Why screening? To detect presence of disease in an asymptomatic population This will allow interventions and we may TREAT / stop progression / prevent worse disease to develop For screening to be effective the disease must be Common, the Population must be covered, and the Test must be good

A good screening test Safe, acceptable to the patient Simple and easy to perform, repeatable Of acceptably low cost Sensitive (correctly identify those with the abnormality) Specific (correctly identify the nondiseased) High predictive value (sens + spec)

Conventional screening for cervical cancer and its precursors Cervical cytology is widely used The taking of a scraping or smear from the cervical surface epithelium for cytological analysis Objective: to detect those women with asymptomatic abnormalities, to detect precursors, to treat those and to prevent the occurrence of cervical cancer

Cytology Nickname: Papsmear (Dr Georges Papanicoloauo 1940’s: staining technique) Criteria: safe, acceptable, easy, reasonably affordable BUT low sensitivity and low specificity If total population is screened repeatedly: can decrease the incidence of CaCx within 20y from 20 down to 6/ women new cases per year

Coverage WHO: all women in a country should get at least one smear in her lifetime; nobody should get a 2 nd smear if some women still have not had a 1 st smear SA: State policy: 3 smears / women / lifetime (ages +/- 30,40,50) (problem in areas with high HIV) SA: private: a commodity: +/- annual

Ideal system? All sexually active women should be screened within the first year of onset of sexual activity, then annually until 3 normal smears have been obtained, then 3yearly Continue until at least y of age

Typical smear results: Bethesda system Normal +/- infectious changes ASC (infectious or atypia) SIL: squamous intraepithelial lesions –Low grade –High grade AGUS Adenocarcinoma in situ Invasive squamous- or adenocarcinoma

Reasons for false positive smears Abnormal smear but no disease: –Atrophy –Infections esp. trichomoniasis –Folic acid deficiency –Previous radiotherapy –Laboratory errors

Reasons for false negative smears Normal smear but missed diagnosis!! –Smear not taken from transformation zone –Too few cells on slide –Deficient fixation of smear –Slide covered with blood or pus –Laboratory errors

Alternatives to cytology 1 Visual screening by inspection –Acetic acid 3% solution applied to cervix –Observe for white change in epithelium (acetowhite) –Can also detect existing cancers –Low sensitivity, specificity, predictive value –Downstaging possible –A real developing world alternative

Alternatives (2) HPV screening (a cost issue…) –Can test for high risk HPV types (PCR test) –Current usage: below 30y: prevalence of HPV infection too high to make conclusions –After age 30y: if HR HPV +: refer for cytology –Advantage: can do HPV in young person with ASC: if also HPV +, rather treat –Ultimately: when more affordable: if both HPV and cytology are -, need to screen again rarely